Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
24,026
Total Claims
$1.1M
Drug Cost
377
Beneficiaries
$2,927
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-97%
Opioid rate vs peers
0.1% vs 2.6% avg
+174%
Cost per patient vs peers
$2,927 vs $1,068 avg
+58%
Brand preference vs peers
14.2% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
16
Opioid Claims
$214
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,396 claims · $844K
Generic: 20,532 claims · $254K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Pimavanserin Tartrate | 53 | $258K |
| Apixaban | 529 | $106K |
| Dulaglutide | 98 | $84K |
| Mirabegron | 156 | $25K |
| Linaclotide | 40 | $21K |
| Insulin Detemir | 60 | $21K |
| Sacubitril/Valsartan | 116 | $20K |
| Collagenase Clostridium Hist. | 27 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 48 | $13K |
| Budesonide | 12 | $11K |
| Rivaroxaban | 80 | $11K |
| Dapagliflozin Propanediol | 67 | $11K |
| Atorvastatin Calcium | 1,317 | $11K |
| Fluticasone/Umeclidin/Vilanter | 31 | $9,737 |
| Mirtazapine | 687 | $8,579 |
Prescribing Profile
Patient Profile
76
Avg Age
64%
Female
2.59
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About